Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Clinical trial NCT01093573 · COMPLETED
Trial details
- NCT number
- NCT01093573
- Sponsor
- Brenda Cooper, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2016-09-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.